USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2024-03-06 обновлены отчеты компании ACRX: 2023 ∙ 2022
  1. Главная
  2. Котировки акций
  3. AcelRx Pharmaceuticals
  4. Мультипликаторы
AcelRx Pharmaceuticals logo
AcelRx Pharmaceuticals ACRX
$ 0.86 7.5%
mail-toСообщить о неточности

AcelRx Pharmaceuticals Мультипликаторы 2011-2024 | ACRX

Мультипликаторы по годам AcelRx Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -0.7 0.1 -0.1 -4.6 -2.6 -3.0 -1.8 -2.7 -6.6 -8.7 -19.9 -3.4 -2.3

P/S

 18.8 2.7 1.0 34.6 59.5 66.8 11.4 6.8 8.3 55.8 15.8 47.3 43.5

EPS

 -1.3 5.7 -5.9 -0.5 -0.7 -0.8 -1.1 -0.9 -0.6 -0.8 -0.6 -1.5 -1.2

EV (Enterprise Value)

 12.8 млн 15.1 млн 109 млн 282 млн 254 млн 172 млн 151 млн 143 млн 147 млн 271 млн 414 млн 96 млн 62.2 млн

EBITDA per Share

 -1.16 -3.2 -5.67 -0.459 -0.663 -0.602 -0.788 -0.66 -0.389 -0.847 -0.153 -1.32 -1.09

EV/EBITDA

 -3.0 -4.7 -2.8 -1.9 -1.6 -2.0 -4.2 -7.0 -64.5 -2.8 -3.1

PEG

 -0.0 0.0 -0.0 -0.16 -0.15 -0.12 0.11 0.04 -0.23 0.29 -0.33 0.11 -0.02

P/B

 0.9 0.2 -0.1 -3.4 -3.3 33.8 -2.5 -22.1 4.8 6.2 6.4 3.3 2.7

P/CF

 -0.7 -0.2 -0.1 -4.6 -2.5 -4.8 -2.8 -3.6 -7.5 -7.3 -123.4 -4.5 -2.7

ROE %

 -130.43 218.92 97.79 72.43 128.54 -1108.61 141.08 808.64 -73.68 -71.49 -32.02 -98.57 -115.07

ROA %

 -90.20 100.56 -45.06 -60.91 -58.28 -39.12 -68.18 -43.16 -19.09 -38.58 -21.29 -51.71 -49.22

ROCE %

 -119.74 -115.98 100.20 -84.18 -69.72 -34.15 -62.50 -35.59 -16.69 -51.78 -6.46 -59.20 -58.66

Current Ratio

 3.2 1.8 0.7 2.7 5.3 6.8 4.6 8.7 9.3 5.6 15.2 4.3 4.9

DSO

 - 16.5 51.5 42.8 82.9 68.0 70.0 122.7 62.3 - - - -

DIO

 - - 133.1 98.4 176.7 78.4 32.7 63.8 96.1 - - - -

DPO

 - - 236.2 165.6 92.2 190.0 48.8 46.2 321.9 - - - -

Операционный цикл

 - 16.5 184.6 141.2 259.6 146.4 102.7 186.5 158.4 - - - -

Финансовый цикл

 - 16.5 -51.6 -24.4 167.4 -43.6 54.0 140.3 -163.5 - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально AcelRx Pharmaceuticals

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 -0.08 -0.4 -0.75 - -0.94 8.58 -1.19 - -1.4 -0.08 -0.08 - -0.1 -0.08 -0.2 -0.18 -0.16 -0.16 -0.17 -0.18 -0.21 -0.2 -0.23 -0.2 -0.28 -0.29 -0.34 -0.21 -0.25 -0.24 -0.24 -0.24 0.11 -0.2 -0.23 -320 20 -240 -220 0.41 -0.26 -0.47 -0.34 -0.41 -0.38 -0.35 -0.36 -0.33 -0.3 -0.25 -0.3

EBITDA per Share

 - - -0.46 - -0.72 -1.73 -0.03 - -1.19 -0.08 -0.08 - -0.09 -0.07 -0.19 - -0.16 -0.16 -0.15 - -0.15 -0.13 -0.16 - -0.16 -0.2 -0.26 - -0.14 -0.16 -0.18 - 0.19 -0.16 -0.25 - -0.11 0.01 - - 0.01 0.01 - - 0.02 0.02 0.01 - 0.02 0.01 0.01

ROE %

 -131.40 -148.78 106.38 211.08 230.54 274.80 88.97 79.63 95.65 92.20 76.68 56.43 91.26 105.98 124.09 128.54 -201.55 -525.21 -803.03 -1108.61 -786.26 -457.69 -174.07 141.08 295.42 473.42 645.48 808.64 595.38 397.04 162.35 -73.68 -71.45 -85.32 -81.12 -71.49 -17.58 -34.04 -35.22 -32.02 -87.40 -97.73 -95.14 -98.57 -103.97 -111.59 -117.60 -115.07 -32.98 -27.27 -18.34

ROA %

 -75.47 -83.61 66.93 99.86 88.27 90.65 -47.61 -34.22 -47.69 -49.57 -47.16 -47.46 -63.24 -63.71 -67.33 -58.28 -52.91 -49.31 -44.47 -39.12 -41.78 -48.67 -57.21 -68.18 -64.77 -58.95 -52.76 -43.16 -41.73 -26.36 -22.23 -19.09 -26.83 -30.02 -35.29 -38.59 -6.45 -17.21 -20.83 -21.29 -53.75 -57.06 -52.36 -51.71 -51.01 -51.81 -52.33 -49.22 -14.11 -11.66 -7.85

ROCE %

 -99.18 -86.13 -127.08 -52.42 -32.35 12.08 80.86 81.37 97.58 93.72 78.15 56.90 89.57 106.04 126.04 94.68 -124.65 -376.66 -577.10 -581.94 -557.67 -314.07 -118.66 84.57 234.00 359.15 487.86 465.04 486.49 358.52 178.06 -37.50 -48.37 -80.69 -56.16 -10.86 -10.86 - - - - - - - - - - - - - -

Current Ratio

 4.7 2.4 2.2 1.9 2.3 2.4 0.7 0.7 0.6 0.7 0.8 0.5 0.5 0.5 0.5 0.7 0.7 0.7 0.7 1.0 1.0 1.0 1.0 0.7 0.7 0.7 0.7 0.9 0.9 0.9 0.9 1.4 1.4 1.4 1.4 2.2 2.2 2.2 2.2 3.0 3.0 3.0 3.0 2.1 2.1 2.1 2.1 1.8 1.8 1.8 1.8

DSO

 - - - - 78.8 43.9 35.5 - 6.3 78.5 115.5 - 42.4 19.8 126.1 83.0 64.8 41.9 82.8 7.3 11.9 5.5 210.4 189.0 94.1 52.6 108.1 82.7 158.1 117.5 137.5 173.3 19.4 155.8 828.3 - - - - - - - - - - - - - - - -

DIO

 - - - - 142.3 101.3 125.5 - 303.4 122.0 133.6 - 80.2 108.3 148.6 - 140.0 166.1 153.9 - 89.1 104.0 74.1 - 43.0 24.6 34.4 - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - 353.1 266.4 281.4 - 433.3 227.1 262.0 - 134.9 182.3 134.6 - 73.1 86.7 140.6 - 215.9 252.2 143.1 - 64.0 36.7 33.0 - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

 - - - - 221.2 145.2 161.0 - 309.7 200.5 249.0 - 122.5 128.1 274.7 83.0 204.8 208.0 236.7 7.3 100.9 109.5 284.6 189.0 137.1 77.2 142.5 82.7 158.1 117.5 137.5 173.3 19.4 155.8 828.3 - - - - - - - - - - - - - - - -

Финансовый цикл

 - - - - -131.9 -121.2 -120.5 - -123.6 -26.5 -13.0 - -12.4 -54.2 140.1 83.0 131.8 121.3 96.1 7.3 -115.0 -142.7 141.5 189.0 73.0 40.5 109.5 82.7 158.1 117.5 137.5 173.3 19.4 155.8 828.3 - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD